Deborah Dunsire is the president and CEO of Millennium:The Takeda Oncology Company. Dr. Dunsire draws on more than 20 years of experience in the scientific, clinical, operational and commercial aspects of the biological/pharmaceutical business. She joined Millennium from Novartis, where she helped increase the North American oncology revenues to over $2.1 billion from approximately $50 million in 10 years. She has received a number of awards, including the Healthcare Businesswomen's Association (HBA) Woman of the Year in 2009; Doctor of Science, Honoris Causa, Worcester (Mass.) Polytechnic Institute; American Cancer Society's Excalibur Award; and the Creative Spirit Award from the Creative Center for Women. She serves on the board of the Biotechnology Industry Organization (BIO), Allergan, Inc., Museum of Science (Boston), CancerCare (New York) and the G&P Foundation for Cancer Research. Dr. Dunsire received her Doctor of Medicine degree from the University of Witwatersand, Johannesburg, South Africa.
The business model for the U.S. automotive industry needs to be re-evaluated to find ways to become competitive again with foreign manufacturers. Innovators and entrepreneurs in Michigan can help drive this... Read more »